What it took to bring breast screening AI across Stockholm

How years of clinical research and real-world experience at Capio S:t Göran helped lay the groundwork for the expansion of breast screening AI across the Stockholm Region.

The journey began with ScreenTrustCAD, a groundbreaking prospective study exploring whether Lunit INSIGHT® MMG could replace one radiologist in Sweden’s double-reading breast screening workflow. The findings gave the team at Capio S:t Göran the confidence to bring AI into clinical practice.


What happened when AI was introduced into breast screening at Capio S:t Göran?

One year after implementing Lunit INSIGHT® MMG as one of two readers, Capio S:t Göran reported a 15% increase in cancer detection, an 11% reduction in recall, and a 31% increase in positive predictive value.

These real-world results helped support the decision to expand breast screening AI across the Stockholm Region.

Read the full story behind the results and the journey from groundbreaking research to real-world implementation and regional expansion.

Read the full story

Have Questions?

Have Questions?

Let’s chat. Get in touch with our team.
Talk to a Specialist